In terms of prevention, a more recent Korean nationwide study on 64 patients concluded that the determination of IgE antibodies to cetuximab or galactose-α-1,3-galactose can accurately predict the future development of anaphylaxis in patients that will receive the drug and can be used in clinical practice [117]. Here, IGHE is linked to anaphylaxis.